# Zimmer Biomet to acquire iovera pain relief device from Pacira for up to $140M

Zimmer Biomet has agreed to pay up to $140 million to acquire Pacira BioSciences' iovera pain relief device, which uses extreme cold for targeted pain relief. The deal includes $70 million upfront and up to $70 million in milestones.

- Type: Acquisition
- Announced: 2026-06-30
- Where: United States
- Value: $140.0M
- Status: announced
- Products: iovera pain relief device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Zimmer Biomet](https://endata.com/companies/30687.md) (acquirer)
- [Pacira BioSciences](https://endata.com/companies/92759.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/zimmer-to-buy-pacira-pain-relief-device-for-up-to-140m/824101/), 2026-06-30: "The acquisition complements Zimmer’s existing product portfolio."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/zimmer-to-acquire-pacira-iovera/), 2026-07-01: "Zimmer Biomet has signed an agreement to acquire US-based Pacira BioSciences’ iovera drug-free medical device for up to $140m."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.